These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 15251435)
1. Histone deacetylase inhibitors regulate p21WAF1 gene expression at the post-transcriptional level in HepG2 cells. Hirsch CL; Bonham K FEBS Lett; 2004 Jul; 570(1-3):37-40. PubMed ID: 15251435 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells. Li H; Wu X Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507 [TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway. Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of p21(WAF1/CIP1) by apicidin, a novel histone deacetylase inhibitor. Kim JS; Lee S; Lee T; Lee YW; Trepel JB Biochem Biophys Res Commun; 2001 Mar; 281(4):866-71. PubMed ID: 11237739 [TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors mediate post-transcriptional regulation of p21WAF1 through novel cis-acting elements in the 3' untranslated region. Hirsch CL; Ellis DJ; Bonham K Biochem Biophys Res Commun; 2010 Nov; 402(4):687-92. PubMed ID: 20977880 [TBL] [Abstract][Full Text] [Related]
8. Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors. Ellis DJ; Lawman ZK; Bonham K Biochem Biophys Res Commun; 2008 Mar; 367(3):656-62. PubMed ID: 18179771 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line. Omotehara F; Nakashiro K; Uchida D; Hino S; Fujimori T; Kawamata H J Exp Clin Cancer Res; 2003 Mar; 22(1):57-60. PubMed ID: 12725323 [TBL] [Abstract][Full Text] [Related]
10. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Park H; Im JY; Kim J; Choi WS; Kim HS Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380 [TBL] [Abstract][Full Text] [Related]
11. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Ahn MY; Jung JH; Na YJ; Kim HS Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664 [TBL] [Abstract][Full Text] [Related]
12. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. Vinodhkumar R; Song YS; Devaki T Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301 [TBL] [Abstract][Full Text] [Related]
13. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells. Noh EJ; Jang ER; Jeong G; Lee YM; Min CK; Lee JS Cancer Res; 2005 Dec; 65(24):11400-10. PubMed ID: 16357148 [TBL] [Abstract][Full Text] [Related]
14. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934 [TBL] [Abstract][Full Text] [Related]
15. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines. Ryu JK; Lee WJ; Lee KH; Hwang JH; Kim YT; Yoon YB; Kim CY Cancer Lett; 2006 Jun; 237(1):143-54. PubMed ID: 16009488 [TBL] [Abstract][Full Text] [Related]
16. Transcription factor Sp1 mediates p38MAPK-dependent activation of the p21WAF1 gene promoter in vascular smooth muscle cells by pyrrolidine dithiocarbamate. Moon SK; Jung SY; Kim CH Biochem Biophys Res Commun; 2004 Apr; 316(3):605-11. PubMed ID: 15033443 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21. Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686 [TBL] [Abstract][Full Text] [Related]
18. The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells. Sakimura R; Tanaka K; Yamamoto S; Matsunobu T; Li X; Hanada M; Okada T; Nakamura T; Li Y; Iwamoto Y Clin Cancer Res; 2007 Jan; 13(1):275-82. PubMed ID: 17200366 [TBL] [Abstract][Full Text] [Related]
19. p21WAF/CIP1/SDI1 is upregulated due to increased mRNA stability during hydroxyurea-induced senescence of human fibroblasts. Kim HS; Yeo EJ; Park SH; Park JI; Park SC; Shin JY; Kim MJ; Oh SJ; Won MH; Kang TC; Park JB; Kim J; Kim JI; Lee HY; Lee JY Mech Ageing Dev; 2005 Dec; 126(12):1255-61. PubMed ID: 16111738 [TBL] [Abstract][Full Text] [Related]
20. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]